CamelX × JJ&K
China
Uniting Saudi innovation with global manufacturing excellence to advance camel-derived biotechnology.
From Saudi innovation to global execution.
In February, CamelX conducted a site visit to its production facility in China, operated within the facilities of its strategic partner, JJ&K, as part of CamelX's global processing network.
The visit marked a key milestone in validating an integrated model designed to support pharmaceutical sovereignty and long-term supply security.
Trusted Production Partner
JJ&K supports CamelX's production pathway through disciplined operations and standardized execution.
Global Processing Network
The partnership connects Saudi biotech ambition with international processing capability across geographies.
Quality-Led Execution
From sourcing to processing, each stage follows defined protocols for quality, traceability, and continuity.
An integrated system of trust.
CamelX is advancing a non-porcine heparin pathway anchored in an end-to-end model that enables national oversight across critical stages of the pharmaceutical value chain.
This model strengthens supply security by connecting research vision, operational control, processing capability, and scalable execution.
Advanced Infrastructure
A specialized production environment designed to support complex pharmaceutical processing.
Operational Discipline
Clear protocols guide each stage, ensuring control, consistency, and standardization.
Shared Vision
An aligned partnership supporting long-term healthcare security and pharmaceutical resilience.
Scalable Growth
An operational model already active across geographies, built for future expansion.
